Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis)

36Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Five cases of heredopathia atactica polyneuritiformis (HAP-Refsum's disease) were treated by serial plasma exchanges. In all patients a reduction in calorie intake and body weight had been associated with a rise in plasma phytanic acid, followed by an exacerbation of the ataxia and neuropathy. Lowering the plasma phytanic acid by plasma exchange produced a rapid clinical improvement. The main indication for plasma exchange in HAP is a severe or rapidly worsening clinical condition. A lesser indication is failure of dietary management to reduce a high plasma phytanic acid level.

Cite

CITATION STYLE

APA

Harari, D., Gibberd, F. B., Dick, J. P. R., & Sidey, M. C. (1991). Plasma exchange in the treatment of Refsum’s disease (heredopathia atactica polyneuritiformis). Journal of Neurology Neurosurgery and Psychiatry, 54(7), 614–617. https://doi.org/10.1136/jnnp.54.7.614

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free